Media coverage
5Media coverage
Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers Nasdaq:IMMU Media name/outlet Global English (Middle East and North Africa Financial Network) Country Jordan Date 9/18/20 Persons Andrew Brenner Title Encouraging Early Stage Clinical Results with Trodelvy(TM) in Brain Cancers Media name/outlet Market News Publishing Country United States Date 9/18/20 Persons Andrew Brenner Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy(TM) in Brain Cancers Media name/outlet Chase Country United States Date 9/18/20 Persons Andrew Brenner Title IMMUNOMEDICS : Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers Media name/outlet MarketScreener.com Country United States Date 9/18/20 Persons Andrew Brenner Title Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy„¢ in Brain Cancers; Results include partial responses in small cohort of patients with brain metastasis from breast cancer (BMBC) and recurrent glioblastoma (rGBM) Media name/outlet PrimeNewswire (Top News) Country United States Date 9/18/20 Persons Andrew Brenner